SKShun-Yu Kan

Shun-Yu Kan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shun-Yu Kan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial Intelligence-Assisted Structural Analysis of Bones with Paget’s Disease of Bone and Osteoporosis: Lessons from Mouse Models

    by Jie Liu, Shun-Yu Kan, Xiwen Xin, Tianle Chen, Henry Tseng, Yung-Chieh Hsu, Tai-Hsien Wu, Do-Gyoon Kim, Ching-Chang Ko

    Background/Objectives: Paget’s disease of bone (PDB) and osteoporosis are chronic metabolic bone disorders characterized by disrupted bone remodeling and increased skeletal fragility; however, the underlying mechanism of PDB remains poorly understood. Artificial intelligence (AI) has emerged as a transformative tool in medical imaging, enabling automated feature extraction and improved diagnostic classification of skeletal disorders. This study aimed to investigate whether AI could distinguish subtle variations in bone morphology between PDB and osteoporotic bone. Methods: C57BL/6 mice femurs were scanned by µCT: 16 optineurin-knockout mice with a PDB phenotype (20–26 months), 25 genetically matched wild-type Aging mice (20–26 months), and 15 ovariectomized (OVX) mice with osteoporotic bone phenotype (4.5 months). Two AI algorithms were investigated: a machine learning (ML) model using 22 µCT-derived features trained with a Random Forest (RF) classifier, and a deep learning (DL) model using a 3D convolutional neural network (3D-CNN) trained on raw µCT images. Leave-one-out cross-validation was applied to evaluate model robustness. Results: Significant differences in volumetric, density, and morphological parameters of cortical and trabecular bone were observed between PDB and osteoporosis (p < 0.05). The RF algorithm achieved 90% accuracy in distinguishing PDB from both aging- and OVX-induced osteoporosis and provided feature importance rankings that improved model interpretability. The 3D-CNN achieved classification accuracies of 70% for PDB vs. OVX and 68% for PDB vs. aging, demonstrating the feasibility of an image-based DL approach. Conclusions: AI-based RF and 3D-CNN models demonstrated promising performance in differentiating PDB from osteoporosis using µCT-derived bone features. These findings suggest potential for using AI to assist with analyzing skeletal images in the diagnosis of metabolic bone disorders.

  • Open Access

    Successful Remission of Refractory Oral Ulcers Treated with Low-Dose Thalidomide and Colchicine: A Case Report

    by Shun-Yu Kan, Yu-Kai Sung, Chia-Lu Hsu, Kuo-Chou Chiu

    Background and Clinical Significance: Oral ulcers are a common disease for dental practitioners. The policy of treating oral ulcers includes removing etiology and medication. Standard management of oral ulcers includes elimination of etiologic factors and pharmacologic therapy. Topical corticosteroids are the most commonly used medicine for oral ulcers. Exclude possible etiologies related to ulcers; refractory ulcers need systemic evaluation and precise medication use to improve patients’ quality and satisfaction. Case Presentation: We present a case of refractory oral ulcers resistant to multiple conventional treatments, which were found to be ineffective. These ulcers significantly impact patient quality of life. We prescribed a series of oral ulcer treatments following the removal of cause factors, such as rounding the teeth and making a soft occlusal bite plate to reduce traumatic sources from the patient’s Parkinson’s disease. A biopsy of the ulcer lesions was also done. All the treatments involving corticosteroids and removing the ulcer-associated etiology were ineffective. Conclusions: Finally, combined therapy using low-dose thalidomide (50 mg/day) and colchicine (1.5 mg/day) resulted in substantial clinical improvement, and complete remission was sustained for over six months without recurrence. A narrative discussion of relevant literature is provided to contextualize therapeutic considerations in refractory oral ulceration. Conclusion: This case suggests that low-dose thalidomide and colchicine combination therapy may be a therapeutic consideration for refractory oral ulcers when conventional management fails; however, the observation is hypothesis-generating and further studies are required to evaluate efficacy and safety.